[Treatment of acute cardiac insufficiency of the acute cor pulmonale variety].

J. Lamelas,J. A. García Torres

Abstract:

What problem does this paper attempt to address?

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

徐秋萍,平玉坤,张烨斐,杨云梅,丁晨彦,张舸

DOI: https://doi.org/10.3760/j.issn:1671-0282.2001.01.014

2001-01-01

Abstract:Objective To evaluate the clinical applications of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema．Methods Thirty one patients with acute cardiogenic pulmonary edema（ACPE）were treated with noninvasive nasal mask bilevel positive airway pressure（BiPAP）．Before and after ventilatory support，the heart rate，breathing rate，urine volume，MAP，SaO2，PetCO2，PaO2，PaCO2 and heart function were recorded．Results After 2～6 hours treatment，the heart rate and breathing rate were significantly reduced（P＜0.001）．The urine volume，SaO2 and PaO2 were markedly increased （P＜0.001）．The MAP were decreased in hypertensive patients（P＜0.001）．All patients’ heart function was improvement．PetCO2and PaCO2 were not changed very much（P＞0.05）．Conclusion The noninvasive nasal mask BiPAP is a kind of safe and effective method in the treatment of ACPE．It can be recommended for clinical use．
The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

张孝钦,王兴祥,丁晨彦,曾蕾

DOI: https://doi.org/10.3969/j.issn.1007-9572.2005.16.024

2005-01-01

Abstract:Objective To compare the therapeutic effect of the continual positive airway pressure (CPAP) ventilation with that of the bilevel positive airway pressure (BIPAP) ventilation in acute cardiogenic pulmonary edema(ACPE).Methods 120 patients with ACPE were randomly allocated to CPAP group and BIPAP group(63 cases in CPAP group and 57 in BIPAP group).Some parameters were observed including the heart rate,breathing rate,MAP,PaO_2,PaCO_2,SpO_2,the intubation′s rate,the therapeutic efficiency rate,resolution time,EICU stay and total hospital stay.Results Resolution time and EICU stay in BIPAP group were significantly shorter than those in CPAP group〔(32.14±7.12)min vs (99.23±15.72)min,P=0.009;(36.04±4.31)h vs (49.32±3.13)h,P=0.002〕.It showed more significant improvement in BIPAP group than in CPAP group during the first 3 hour of the therapy,such as HR,R,PaO_2,PaCO_2.There were no differences between two groups in the intubation′s rate,the efficiency rate and total hospital stay(P0.05).Conclusion BIPAP is more effective in the early therapy than CPAP in ACPE,and the final therapeutic effect of the two methods is similar.
The Clinical Study on Seventy Four Patients with Acute Pulmonary Contusion

施小燕,马岳峰,洪远

DOI: https://doi.org/10.3760/j.issn:1671-0282.2002.05.014

IF: 1.473

2002-01-01

Journal of Emergency Medicine

Abstract:Objective To study the therapeutic effect of liposomal prostaglandin E 1(lipo PGE 1)on severe pulmonary contusion.Methods From January 1998 to August 2000 seventy four patients (ISS≥20)with severe pulmonary contusion were selected in the study.The patients were mechanically ventilated because of severe hypoxia.They were divided randomly into two groups:control group and lipo PGE 1 group.In the control group( n =38)the patients were treated only with routine therapy.In lipo PGE 1 group( n =36)they received an intravenous bolus of lipo PGE 1 followed by a dose of 3ng.kg -1 .min -1 infusion of 2h and q12h for 7 days.Results In the lipo PGE 1 group,the total duration of assisted ventilation was less than that in the control group( P 0 001).The average stay in the intensive care unit of lipo PGE 1 group was lower than that in the control group( P 0 001).Blood gas analyses(PaO 2,PaO 2/FiO 2)of the patients from the PGE 1 group was improved(p0 01)after treatment within 72h,but that from the control group was not improved( P 0 05).From X rays,the inflammatory change of lung recovered sooner in the lipo PGE 1 group than it did in the control groups.Conclusion The treatmemt of pulmonary contusion by lipo PGE 1,resulted in speedy recovery,better ultimate pulmonary functions,and it proved to be cost effective. [
Identification of oligodendrocyte precursors in the myelinated streak of the adult rabbit retina in vivo

Y. Morcos,T. Chan-Ling

DOI: https://doi.org/10.1002/(SICI)1098-1136(199710)21:2<163::AID-GLIA1>3.0.CO;2-8

1997-10-01

Glia

Abstract:Whole‐mount techniques have been applied to the myelinated axons of the rabbit retina in order to study oligodendrocytes in the developing and adult central nervous system in vivo. Retinas from rabbits on embryonic day (E) 26 to postnatal day (P) 50 and from adults were subjected to immunohistochemistry with antibodies to glial fibrillary acidic protein (GFAP), vimentin, glycolipid O4, myelin basic protein (MBP), galactocerebroside (Gal‐C), 4D6, and Griffonia simplicifolia isolectin, markers chosen for their specificity for astrocytes, cells of the oligodendrocyte lineage, Müller cells, and microglia. The first glial cells labelled within the myelinated streak (MS) were vimentin+ astrocytes. These cells were first apparent near the optic disc at E26. Their numbers and distribution increased markedly between E26 and E30, but between E29 and P3, vimentin expression was replaced by GFAP expression. Between P3 and P4, O4+, Gal‐C−, MBP− oligodendrocyte precursor cells, O4+, Gal‐C−, MBP− pre‐oligodendrocytes, and O4+, Gal‐C+, MBP− immature oligodendrocytes appeared in low numbers in the region adjacent to the optic nerve head. O4−/+, Gal‐C+, MBP+ mature oligodendrocytes appeared soon after at P4 to P5. With age, the outer extent of Gal‐C and MBP immunoreactivity expanded, with positive cells forming a continuous sheath around nerve fibre bundles. The sequence of gliogenesis in the (MS) of the rabbit retina thus appears similar to that in the rat optic nerve. In adult rabbits, a large population of O4+ cells was distributed across the MS, the outer limit of the cells coinciding with the outer limit of retinal vessels. These O4+ cells could be classified into three stages of differentiation on the basis of expression of developmental markers and morphology: O4+, Gal‐C−, MBP− oligodendrocyte precursor cells with a bipolar, unipolar, or simple morphology; O4+, Gal‐C−, MBP− pre‐oligodendrocytes with a complex multipolar morphology; and O4+, Gal‐C+, MBP− immature oligodendrocytes with a complex multipolar morphology. The final stage of differentiation was characterized as O4−, Gal‐C+, MBP+ mature oligodendrocytes with multiple parallel processes aligned along nerve fibre bundles. These results provide in vivo evidence for the existence of a substantial population of oligodendrocyte precursor cells and non‐myelin–producing immature oligodendrocytes in the MS of the adult rabbit retina. This preparation makes possible in situ patch clamping and determination of other functional responses of these cell types in vivo. GLIA 21:163–182, 1997. © 1997 Wiley‐Liss, Inc.
Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Y. L. Liu,J. B. Huang,B. Kong,S. S. Hu,X. D. Shen,S. J. Li,X. Wang,J. Yan,X. Wu

DOI: https://doi.org/10.3969/j.issn.1008-0074.2003.05.017

2003-01-01

Abstract:Objective: To study the experience and efficacy of 32 patients with congenital heart disease combined with severe pulmonary hypertension. Methods:The clinical data of 32 patients were studied retrospectively. All the patients showed cyanosis after physical activity and accepted echocardiogram measure showed bi-directed shunt at the defects. The intracardiac malformation included ventricular septal defects (VSD) 22 cases, VSD with atrial septal defects (ASD) 5 cases, VSD with patent ductus arteriosus (PDA) 5 cases. Among 32 cases, 6 cases were accepted the operation on cardioplegic heart arrested, while 26 on beating heart. Using auto-pericardium repaired ASD and made a valve that allowed only right-to-left shunt. If no ASD, the valve was done at the oval fosse. Results: There were 3 cases of early surgical deaths (9.4%, 3/32). Every patient accompanied with hypoxia, and need more long mechanical support but no case needs tracheolaryngotomy. There were 2 (6. 3%, 2/32) cases of late deaths and 3 (9.4%, 3/32) cases of late heart function failure followed-up from two months to eighty-six months. The other patients (75%, 24/32) recovered well. Conclusion: On-pump with beating heart is an effective myocardial protective technique in patients with congenital heasrt disease combined with severe pulmonary hypertension. It contribute to early recovery for the patients with severe pulmonary hypertension by doing the valves on atrial septum.
Acute decompensated pulmonary hypertension

Laurent Savale,Jason Weatherald,Xavier Jaïs,Constance Vuillard,Athénaïs Boucly,Mitja Jevnikar,David Montani,Olaf Mercier,Gerald Simonneau,Elie Fadel,Olivier Sitbon,Marc Humbert

DOI: https://doi.org/10.1183/16000617.0092-2017

2017-11-15

Abstract:Acute right heart failure in chronic precapillary pulmonary hypertension is characterised by a rapidly progressive syndrome with systemic congestion resulting from impaired right ventricular filling and/or reduced right ventricular flow output. This clinical picture results from an imbalance between the afterload imposed on the right ventricle and its adaptation capacity. Acute decompensated pulmonary hypertension is associated with a very poor prognosis in the short term. Despite its major impact on survival, its optimal management remains very challenging for specialised centres, without specific recommendations. Identification of trigger factors, optimisation of fluid volume and pharmacological support to improve right ventricular function and perfusion pressure are the main therapeutic areas to consider in order to improve clinical condition. At the same time, specific management of pulmonary hypertension according to the aetiology is mandatory to reduce right ventricular afterload. Over the past decade, the development of extracorporeal life support in refractory right heart failure combined with urgent transplantation has probably contributed to a significant improvement in survival for selected patients. However, there remains a considerable need for further research in this field.
[Peracetic acid as disinfectant--a review].

H. Flemming

1984-05-01

Abstract:
Lung morphology and surfactant function in cardiogenic pulmonary edema: a narrative review.

Pablo Paz,R. Rahman,M. Elmassry,K. Nugent,L. Dobbe

DOI: https://doi.org/10.21037/jtd.2019.09.02

2019-09-20

Journal of Thoracic Disease

Abstract:The conventional analysis of acute cardiogenic pulmonary edema involves the development of high pulmonary capillary pressures resulting in hydrostatic gradients for fluid flux out of capillaries into the interstitial space and alveolar spaces. However, some patients respond poorly to diuretic management. The PubMed database was searched to identify experimental studies on pulmonary edema in animals, experimental studies on surfactant function, including patients with pulmonary edema, and clinical studies reporting barrier dysfunction and/or injury in patients with acute pulmonary edema. Studies with animal models demonstrate that high capillary pressures can cause barrier disruption in alveolar capillary units which increases permeability and the transfer of fluid and protein into lung parenchyma. Fluid in alveolar spaces alters surfactant function which increases fluid flux out of capillaries into the lung parenchyma secondary to larger transcapillary hydrostatic gradients. Patients with acute cardiogenic pulmonary edema have increased levels of surfactant protein B in their plasma which reflect barrier disruption and increased levels of tumor necrosis factor alpha which reflect acute tissue injury. Increased surfactant protein B plasma levels are associated with abnormal gas exchange in patients with chronic heart failure. Patients with exercise-induced left ventricular dysfunction have increased levels of surfactant protein B after short periods of exercise. Pathology studies in patients with chronic heart failure have found increased connective tissue in alveolar capillary units and increased numbers of type II alveolar cells, and these changes represent an adaptive response in these patients. Clinicians need to consider the possibility of barrier dysfunction and disruption in patients with both acute and chronic pulmonary edema and understand that diuresis may have a limited effect on symptoms in some patients.

Medicine
Effect of Noninvasion Mechanical Ventilation Combination with Injection of Fasudil in Cor Pulmonale Patients with Respiratory Failure

WANG Mei-fang,LIU Yu-quan,XIONG Chang,TANG Yi-jun,LU Jin-chang,WANG Yun,LIU Xian-jun

DOI: https://doi.org/10.3969/j.issn.1009-6663.2013.04.043

2013-01-01

Abstract:Objective To investigate the curative effects of noninvasion mechanical ventilation(NMV) combination with injection of fasudil on cor pulmonale patients complicated with respiratory failure.Methods Sixty patients with cor pulmonale complicated with respiratory failure were randomly divided into treatment group and routine group.Patients in routine group(30 cases) were treated by NMV combined with routine therapy while patients in treatment group(30 cases) usage of fasudil substition for phentolamine.The clinical efficacy was observed.The concentrations of plasma BNP and pulmonary hypertension were also measured at the beginning and 72 h later.Results Treatment group had a significantly higher overall response rate83.3%,compared with routine group(P0.05).Pulmonary systolic pressure and plasma levels of BNP were significantly decreased after treatment in both groups,especially in the fusudil group(P0.01).Conclusion Noninvasion mechanical ventilation combination with injection of fasudil can improve ventilatory function and decrease the level of pulmonary systolic pressure and BNP improving the patient′s heart function in short time in cor pulmonale complicated with respiratory failure highlighting the good clinical efficacy.
[Extracorporeal lung assist in severe respiratory failure and ARDS. Current situation and clinical applications]

Abel Gómez-Caro,Joan Ramon Badia,Pilar Ausin

DOI: https://doi.org/10.1016/j.arbres.2010.05.005

Abstract:Despite improvements in ventilation support techniques, lung protection strategies, and the application of new support treatment, acute respiratory distress syndrome continues to have a high mortality rate. Many strategies and treatments for this syndrome have been investigated over the last few year. However, the only therapeutic measure that has systematically shown to be able to improve survival is that of low volume lung protective ventilation. Thus, using a low tidal volume prevents added lung damage by the same mechanical ventilation that is essential for life support. In this context, the use of extracorporeal lung assist systems is considered an exceptional use rescue treatment in extreme cases. On the other hand, it could be a potentially useful complementary method for an ultra-protective ventilation strategy, that is, by using even lower tidal volumes. The currently available extracorporeal lung assist systems are described in this article, including high flow systems such as traditional extracorporeal membrane oxygenation, CO₂ removal systems (interventional lung assist or iLA, with or without associated centrifugal pumps), and the new low flow and less invasive systems under development. The aim of this review is to update the latest available clinical and experimental data, the indications for these devices in adult respiratory distress syndrome (ARDS), and their potential indications in other clinical situations, such as the bridge to lung transplantation, multiple organ dysfunction syndrome, or COPD.
Treatment Efficary and Apply Juncture of Glucocorticoid of Acute Lung Injury and Acute Respiratory Distress Syndrome

CAO Zhao-long,HE Quan-ying

2007-01-01

Abstract:Acute lung injury and acute respiratory distress syndrome(ALI/ARDS) is a popular emergency of all clinician.the pathogenesis of ALI/ARDS is migration of neutrophil to inflammation site.which release massive inflammatory mediator and cytokines. It can increase alveolar-capillary membrane permeability, diffuse alveolar damage, alveolar pulmonary edema. Clinical manifestation is dyspnea, distress, intractable hypoxemia. The mortality sustains about 50%, although we use the mechanical ventilation and post end-expiratory pressure(PEEP), the mortality is decrease in some degree.To overview the mechanism of glucocorticoid, effect of ALI/ARDS of defferent causes,and apply juncture. We hope it may specifit treatment of glucocorticoid to ALI/ARDS.
[Acute cardiogenic pulmonary edema].

P. Stainier,L. Pierard,P. Lancellotti,V. Smeets

Abstract:Acute cardiogenic pulmonary oedema frequently occurs in clinical practice, frequently in an old patient. It consists in acute respiratory distress related to rapid development of transsudative fluid within the lung interstitium and alveolar accumulation. It requires rapid assessment and therapy to prevent progression to respiratory failure and cardiovascular collapse. The pathogenesis and identification of the underlying disease process are essential for optimal medical approach. The aetiology is multiple.

Medicine
Treatment of acute lung injury after surgical treatment of cyanotic congenital heart disease

FU Zhi-kun,DONG Zi-chao,YAO Wei,CHEN Xiao-san,ZHAO Jun,GU Xiao-wei,DU Hong

DOI: https://doi.org/10.13191/j.chj.2012.06.87.fuzhk.031

2012-01-01

Abstract:AIM:To analyze the causes of acute lung injury(ALI) after surgical treatment of cyanotic congenital heart disease(C-CHD) and to summarize the postoperative therapeutic experience.METHODS: Included in the study were 79 patients with C-CHD who underwent surgical treatment in our hospital from March 2007 to October 2011;12 patients developed ALI postoperatively.Transcutaneous oxygen saturation(SpO2),hematocrit(HCT),McGoon ratio,Nakata index and CPB data and therapeutic data of the 12 patients with ALI were collected.RESULTS: There were 12 cases complicated by ALI with a morbidity of 15%.The mean age of the 12 patients was(19±8) months(8-63 months) and the mean body weight was(15±4) kg(8-25 kg).Surgical procedures of the 12 cases were all performed under intravenous-inhalation combined anesthesia and cardiopulmonary bypass(CPB) and modified ultrafiltration was used postoperatively.Total CPB time and aortic clamp time were(117±12) min and(81±13) min,respectively.Peritoneal dialysis(PD) was performed in 11 cases.Five patients were given inhaled nitric oxide(NO) and one patient was given pulmonary surfactant(PS).Four patients died and the total mortality rate was 33.3%.CONCLUSION: Incidence of ALI after surgical treatment of C-CHD is high.Proper mechanical ventilation and appropriate fluid balance will improve pulmonary function as well as early recovery of the patients.A positive PS replacement or NO inhalation therapy may be useful.
Should Noninvasive Ventilation Be Used for Treatment of Acute Cardiogenic Pulmonary Edema? A Cochrane Review Summary With Commentary

Dean R Hess

DOI: https://doi.org/10.4187/respcare.07685

2020-03-25

Respiratory Care

Abstract:Acute cardiogenic pulmonary edema is common in patients with heart disease. It can result in derangements in gas exchange and hemodynamics, leading to hypoxia and death. Standard medical care includes oxygen, diuretics, morphine, and an afterload reducer such as nitroglycerin. Noninvasive

respiratory system,critical care medicine
Glucocorticoids in the treatment of acute respiratory distress syndrome

F. Roche-Campo,H. Aguirre-Bermeo,J. Mancebo

DOI: https://doi.org/10.1007/s13546-011-0316-1

2011-10-25

Réanimation

Abstract:Acute respiratory distress syndrome (ARDS) is characterized by local inflammation and an intense systemic inflammatory reaction. Glucocorticoid administration has been suggested due to their anti-inflammatory properties. However, results from the initial studies of glucocorticoids in ARDS, which evaluated high-dose and short-term treatments, were negative. More recent studies have evaluated the effect of lower doses of glucocorticoids administered over longer periods, but the results thus far have been inconclusive.
Acute Cardiogenic Pulmonary Edema: Clinical and Noninvasive Evaluation

Alan J. Bier,Peter Q. Eichacker,Lawrence I. Sinoway,Sachiko M. Terribile,Joel A. Strom,Deborah L. Keefe

DOI: https://doi.org/10.1177/000331978803900302

1988-03-01

Angiology

Abstract:Left ventricular echocardiograms performed within ninety-six hours of ad mission were prospectively correlated with the clinical course in 87 consecutive patients admitted with acute pulmonary edema. Patients were stratified into four groups based on their two-dimensional echocardiogram: hyperdynamic, normal, mildly reduced, and severely reduced. Echocardiographic estimates of left ventricular function were compared with their ejection fraction measured by the gated radioisotope technique. The authors found that 48% of the patients were either normal or hyperdynamic (38% and 10% respectively). Patients in these two groups had a greater incidence of left ventricular hypertrophy (wall thickness > 13mm) (66% vs 39%, p 160/100) (66% vs 41%, p=.05), and smaller end-diastolic dimension (p < .05) than those with decreased left ventricualr function. The authors con clude that echocardiography is a good screening test of left ventricular function in patients presenting with pulmonary edema. Patients with normal or in creased left ventricular systolic function should be evaluated for correctable or treatable causes of acute pulmonary edema.

peripheral vascular disease
Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study)

Lucrecia María Burgos,Rocio Consuelo Baro Vila,Franco Nicolás Ballari,Ailin Goyeneche,Juan Pablo Costabel,Florencia Muñoz,Ana Spaccavento,Martín Andrés Fasan,Lucas Leonardo Suárez,Martin Vivas,Laura Riznyk,Sebastian Ghibaudo,Marcelo Trivi,Ricardo Ronderos,Fernando Botto,Mirta Diez,CAVAL US—AHF group

DOI: https://doi.org/10.1016/j.ahj.2024.07.015

Abstract:Background: The optimal assessment of systemic and lung decongestion during acute heart failure is not clearly defined. We evaluated whether inferior vena cava (IVC) and pulmonary ultrasound (CAVAL US) guided therapy is superior to standard care in reducing subclinical congestion at discharge in patients with AHF. Methods: CAVAL US-AHF was an investigator-initiated, single-center, single-blind, randomized controlled trial. A daily quantitative ultrasound protocol using the 8-zone method was used and treatment was adjusted according to an algorithm. The primary endpoint was the presence of more than 5 B-lines and/or an increase in IVC diameter and collapsibility at discharge. And secondary endpoint exploratory outcome was the composite of readmission for HF, unplanned visit for worsening HF or death at 90 days RESULTS: Sixty patients were randomized to CAVAL US (n = 30) or control (n = 30). The primary endpoint was achieved in 4 patients (13.3%) in the CAVAL US group and 20 patients (66.6%) in the control group (P < .001). A significant reduction in HF readmission, unplanned visit for worsening HF or death at 90 days was seen in the CAVAL US group (13.3% vs 36.7%; log rank P = .038). Other endpoints such as NT-proBNP reduction at discharge showed a nonstatistically significant reduction in the CAVAL US group (48% IQR 27-67 vs 37% -3-59; P = .09). Safety outcomes were similar in both groups. Conclusion: IVC and lung ultrasound-guided therapy in AHF patients significantly reduced subclinical congestion at discharge. CAVAL US-AHF provides preliminary evidence for the potential use of a simple technique to guide decongestive therapy during hospitalization for AHF, which may reduce the composite outcome at 90 days.
Clinical research on the postoperative treatment results of congenital heart disease patients with serious pulmonary hypertension

Qiao Jian-hua,Feng Gang,Yang Gui-ying

DOI: https://doi.org/10.3969/j.issn.1009-3257.2006.06.001

2006-01-01

Abstract: Objective to study the surgical treatment of congenital heart disease with seriouspulmonary hypertension. Methods the clinical data of 117 patients with congenital heartdisease patients with serious pulmonary hypertension and early Eisenmenger’s Syndrome wereanalyzed retrospectively, some details combined with related literature were construed in thefields of selecting operative indication, improving operative method and handling work aroundof operative period. Results 116 patients were alived and 1 patients was dead. If the PO2is 9Kpa(67.5mmHg)or less , the patient should probably not undergo the operation;if PO2is between 9Kpa(67.5mmHg) and 11Kp(a82.5mmHg),the patient is at increased risk;if thePO2 is 11Kpa(82.5mmHg)or more, the operation shoule be accepted。 Conclusion themost of congenital heart disease patients with serious pulmonary hypertension or earlyEisenmenger’s Syndrome were not absolute operative constraindication, through specialpreoperative and postoperative synthetical treatment and improving operative technology, themost of the congenital heart disease patients with serious pulmonary hypertension or earlyEisenmenger’s Syndrome can be treated and cured by operation, and long-term curativeeffect to be satisfactory. More long-term curative effect to be observed and followed up acase by regular visits to or correspondence with a patient.
Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

H. Hermann,Jordis Arp,B. Pieske,H. Kögler,Steffen Baron,Paul M.L. Janssen,G. Hasenfuss

DOI: https://doi.org/10.1016/j.ejheart.2003.10.001

2003-12-13

European Journal of Heart Failure

Abstract:
Clinicopathologic conference; polycystic kidneys with generalized osteitis fibrosa cystica and parathyroid hyperplasia.

R. H. Turner,E. Farber,J. V. Hopkins

1952-03-01

Abstract:

[Treatment of acute cardiac insufficiency of the acute cor pulmonale variety].

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

The Clinical Study on Seventy Four Patients with Acute Pulmonary Contusion

Identification of oligodendrocyte precursors in the myelinated streak of the adult rabbit retina in vivo

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Acute decompensated pulmonary hypertension

[Peracetic acid as disinfectant--a review].

Lung morphology and surfactant function in cardiogenic pulmonary edema: a narrative review.

Effect of Noninvasion Mechanical Ventilation Combination with Injection of Fasudil in Cor Pulmonale Patients with Respiratory Failure

[Extracorporeal lung assist in severe respiratory failure and ARDS. Current situation and clinical applications]

Treatment Efficary and Apply Juncture of Glucocorticoid of Acute Lung Injury and Acute Respiratory Distress Syndrome

[Acute cardiogenic pulmonary edema].

Treatment of acute lung injury after surgical treatment of cyanotic congenital heart disease

Should Noninvasive Ventilation Be Used for Treatment of Acute Cardiogenic Pulmonary Edema? A Cochrane Review Summary With Commentary

Glucocorticoids in the treatment of acute respiratory distress syndrome

Acute Cardiogenic Pulmonary Edema: Clinical and Noninvasive Evaluation

Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study)

Clinical research on the postoperative treatment results of congenital heart disease patients with serious pulmonary hypertension

Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

Clinicopathologic conference; polycystic kidneys with generalized osteitis fibrosa cystica and parathyroid hyperplasia.